2-[N-Acylamino(C1−C3)alkyl]indoles as MT1 Melatonin Receptor Partial Agonists, Antagonists, and Putative Inverse Agonists
The synthesis of several novel indole melatonin analogues substituted at the 2-position with acylaminomethyl (8 − 11), acylaminoethyl (5a − k), or acylaminopropyl (13) side chains is reported. On the basis of a novel in vitro functional assay (specific binding of [35S]GTPγS), which can discriminate...
Gespeichert in:
Veröffentlicht in: | Journal of medicinal chemistry 1998-09, Vol.41 (19), p.3624-3634 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The synthesis of several novel indole melatonin analogues substituted at the 2-position with acylaminomethyl (8 − 11), acylaminoethyl (5a − k), or acylaminopropyl (13) side chains is reported. On the basis of a novel in vitro functional assay (specific binding of [35S]GTPγS), which can discriminate agonist from partial agonist, antagonist, and inverse agonist ligands, 5a,g,h,j and 13 were shown to be partial agonists, 5d,e and 8 − 11 competitive antagonists, and 5b,c,k putative inverse agonists. Binding and functional assays were performed on cloned human MT1 receptor. Structure−activity relationship considerations indicate that N-[1-aryl-2-(4-methoxy-1H-indol-2-yl)(C1−C2)alkyl]alkanamides represent a lead structure for this type of ligands. |
---|---|
ISSN: | 0022-2623 1520-4804 |
DOI: | 10.1021/jm970721h |